What is LOPJLB’s current signal on JUNS?

LOPJLB’s latest quantitative signal on Jupiter Neurosciences, Inc. (JUNS) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is JUNS in?

Jupiter Neurosciences, Inc. (JUNS) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Jupiter Neurosciences, Inc. (JUNS) do?

Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main objective of addressing neuro-inflammation. The company's pipeline includes several drug candidates: JNS101 is undergoing Phase II trials for Friedreich's Ataxia, a rare neurological disorder that damage…